Constructive Bio Garners $58M to Revolutionise Biofactories from Living Cells
Constructive Bio, a trailblazer in synthetic genomics, has secured a remarkable $58 million in Series A funding, spearheading advances in biofactory technology.Established recently as a University of Cambridge spinout, the…



